Semaglutide is a GLP-1 receptor agonist FDA-approved for chronic weight management in adults with obesity (BMI ≥ 30) or overweight (BMI ≥ 27) with a qualifying comorbidity. Residents of Austin, Texas can access licensed Semaglutide prescriptions through telehealth — no in-person clinic visit required under Texas Occupations Code §111.001. Board-certified physicians review patient health assessments online and issue prescriptions within 24–48 hours. Compounded Semaglutide from an FDA-registered 503B outsourcing pharmacy ships overnight directly to your Austin address. Monthly cost: $199–$379 — vs. $1,247 for brand-name Ozempic or Wegovy. All prescribing physicians serving Austin patients are licensed in Texas and regulated by the Texas Medical Board. Medical Director: Dr. Sarah Chen, MD, Board-Certified Internal Medicine. Serving Austin ZIP codes: 78701, 78702, 78703, 78704, 78705.
Local clinics serving Austin: Texas Weight Loss - North Austin, Texas Weight Loss - South Austin and Austin Plastic Surgeon: Johnny Franco, MD. Many patients compare these in-person options against licensed Semaglutide telehealth — prescribed online, shipped to the door.
Semaglutide seen from Austin, without the jargon. Semaglutide is taken once a week as a subcutaneous injection - a cadence that has done a lot to drive its adoption over daily treatments.
A consultation, even online, exists precisely to check these criteria before any prescription. The goal of the evaluation is not to screen for the sake of screening, but to make sure the expected benefit outweighs the risks.
For a Austin resident, Semaglutide is now largely managed remotely, home delivery included. On the cost side, expect about $200-500/month compounded via telehealth; about $1,000-1,350/month brand-name without insurance. depending on the format (brand vs compounded). Associated brands include Ozempic, Wegovy, Rybelsus. Around Austin in Travis County, 3 weight-management practice(s) are listed locally.
Often a BMI of 30 or higher, or 27 or higher with a weight-related comorbidity, but only the medical evaluation decides.
Most patients notice reduced appetite within the first 1-2 weeks; clinically meaningful weight loss usually appears between week 8 and week 12 as the dose increases.
Ozempic is a brand of semaglutide dosed for diabetes; Wegovy is the same active ingredient dosed for weight loss. Semaglutide is the shared generic molecule.
Medical Director: Dr. Sarah Chen, MD, Board-Certified Internal Medicine. Licensed in Texas. All prescriptions issued under Texas Occupations Code §111.001 and supervised by Texas Medical Board.